Literature DB >> 8396500

Synthetic studies of vitamin D analogues. XIV. Synthesis and calcium regulating activity of vitamin D3 analogues bearing a hydroxyalkoxy group at the 2 beta-position.

K Miyamoto1, E Murayama, K Ochi, H Watanabe, N Kubodera.   

Abstract

Four vitamin D3 analogues (7a, 7b, 7c and 7d) bearing a hydroxyalkoxy group at the 2 beta-position were synthesized from the alpha-epoxide (5). The C-3 analogue (7b) showed the highest potency for elevating plasma calcium levels in rats. Furthermore, the 25-hydroxylated C-3 analogue (ED-71) (3), prepared from the 25-hydroxylated alpha-epoxide (9), significantly increased plasma calcium to levels much higher than those in rats administered 1 alpha,25-(OH)2-D3 (1).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396500     DOI: 10.1248/cpb.41.1111

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

Review 1.  Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.

Authors:  Toshio Matsumoto; Toshiyuki Takano; Hitoshi Saito; Fumiaki Takahashi
Journal:  Bonekey Rep       Date:  2014-03-05

2.  Osteoporosis treatment by a new active vitamin D3 compound, eldecalcitol, in Japan.

Authors:  Toshio Matsumoto
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

3.  Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.

Authors:  A Sakai; M Ito; T Tomomitsu; H Tsurukami; S Ikeda; F Fukuda; H Mizunuma; T Inoue; H Saito; T Nakamura
Journal:  Osteoporos Int       Date:  2015-01-16       Impact factor: 4.507

4.  Human hepatic metabolism of the anti-osteoporosis drug eldecalcitol involves sterol C4-methyl oxidase.

Authors:  Kaori Yasuda; Yuasa Iwanaga; Kazuaki Ogawa; Hiroki Mano; Sera Ueno; Shutaro Kimoto; Miho Ohta; Masaki Kamakura; Shinichi Ikushiro; Toshiyuki Sakaki
Journal:  Pharmacol Res Perspect       Date:  2015-02-10

5.  Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice.

Authors:  Yoshihisa Hirota; Kimie Nakagawa; Keigo Isomoto; Toshiyuki Sakaki; Noboru Kubodera; Maya Kamao; Naomi Osakabe; Yoshitomo Suhara; Toshio Okano
Journal:  PLoS One       Date:  2018-10-03       Impact factor: 3.240

6.  Comparative effect of eldecalcitol and alfacalcidol on bone microstructure: A preliminary report of secondary analysis of a prospective trial.

Authors:  Xiaolin Ni; Juan Feng; Yan Jiang; Li Zhang; Wei Yu; Ou Wang; Mei Li; Xiaoping Xing; Toshio Matsumoto; Weibo Xia
Journal:  Osteoporos Sarcopenia       Date:  2021-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.